Smart Lens
Now in U.S. Pivotal Trials

The New Frontier in Ophthalmic Care

Transforming anterior segment disease management through breakthrough technologies. Continuous IOP monitoring for better glaucoma outcomes.

24-Hour IOP Monitoring
12 AM6 AM12 PM6 PM12 AM
Peak IOP
24 mmHg
Avg IOP
19.2 mmHg
Status
Normal Range

Transforming Anterior Segment Disease Management

Smartlens is redefining anterior segment disease management through breakthrough technologies that address critical unmet needs. We're enabling a paradigm shift from episodic office visits to continuous, data-driven treatment across multiple conditions. By combining novel microfluidic technology with AI-enhanced diagnostics, we enable precise, real-time tracking and personalized care management for glaucoma and beyond.

Glaucoma in Numbers

The global burden of glaucoma and the urgent need for better monitoring

>140M
People suffering from glaucoma worldwide
56%
Undiagnosed population in the US
38%
Patients with irreversible blindness in EU
20%
Are at severe stage (high risk of blindness)
96.2%
Practitioners indicating adoption intent

Technology Portfolio

Redefining care for anterior segment diseases through breakthrough monitoring, diagnostics, and treatment technologies

miLens™

In U.S. Pivotal Trials

The world's smallest wearable microfluidic device for remote IOP monitoring. Non-invasive, electronics-free contact lens design works seamlessly with our AI-powered smartphone imaging system. Captures critical pressure variations missed by quarterly or annual measurements.

24-Hour MonitoringUltra-Sensitive TechnologyPatent Protected

Slit IQ™

In U.S. Pivotal Trials

AI-powered remote examination platform enabling comprehensive anterior segment exams with clinical-grade standardization. 50% of all eye care visits can potentially be performed through Slit IQ™, expanding specialist access and reducing unnecessary in-person visits.

Telemedicine EnabledAI-EnhancedClinical-Grade

THERx IQ™

In Pilot Trials

Novel wearable device addressing poor medication adherence through automated micro-dose delivery. Programmable platform optimizes treatment timing based on actual diurnal IOP patterns, enhancing therapeutic efficacy while minimizing side effects.

Automated DosingProgrammableMicro-Dosing

miLens IQ+™

AI/ML Platform

AI/ML-powered platform unlocking insights from first-of-its-kind diurnal IOP monitoring and comprehensive imaging data. Provides real-time risk stratification and predictive capabilities for early intervention before significant disease progression.

Predictive AnalyticsRisk StratificationData Integration

Complete Practice Management

Everything you need to manage your ophthalmology practice and monitor patient IOP data

Real-Time Data Access

Access patient IOP data in real-time through our cloud platform. Monitor trends, view historical data, and generate comprehensive reports for better clinical decision-making.

Multi-Practice Management

Manage multiple clinic locations from a single dashboard. Role-based access control ensures HIPAA-compliant data handling across your organization.

Secure & Compliant

Enterprise-grade security with full audit trails. Built for HIPAA compliance with encrypted data storage and transmission to protect patient privacy.

Ready to Transform Your Practice?

Join healthcare providers who are revolutionizing glaucoma care with continuous IOP monitoring.

Smart Lens
© 2018 - 2025 Smartlens, Inc. All rights reserved.